PHR

Insider Sale: SVP of $PHR Sells 500 Shares

David Linetsky, the SVP of $PHR, sold 500 shares of the company on 01-29-2025 for an estimated $14,841. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2% of their shares of this class of stock. Following this trade, they now own 230,771 shares of this class of $PHR stock.

$PHR Insider Trading Activity

$PHR insiders have traded $PHR stock on the open market 77 times in the past 6 months. Of those trades, 0 have been purchases and 77 have been sales.

Here’s a breakdown of recent trading of $PHR stock by insiders over the last 6 months:

  • EVAN ROBERTS (Chief Operating Officer) has made 0 purchases and 11 sales selling 68,114 shares for an estimated $1,753,873.
  • CHAIM INDIG (Chief Executive Officer) has made 0 purchases and 7 sales selling 64,689 shares for an estimated $1,725,356.
  • ALLISON C HOFFMAN (General Counsel & Secretary) has made 0 purchases and 12 sales selling 53,295 shares for an estimated $1,406,258.
  • MICHAEL WEINTRAUB has made 0 purchases and 4 sales selling 55,152 shares for an estimated $1,321,348.
  • DAVID LINETSKY (SVP, Life Sciences) has made 0 purchases and 18 sales selling 48,153 shares for an estimated $1,258,075.
  • AMY BETH VANDUYN (SVP, Human Resources) has made 0 purchases and 8 sales selling 36,918 shares for an estimated $838,378.
  • BALAJI GANDHI (Chief Financial Officer) has made 0 purchases and 7 sales selling 19,037 shares for an estimated $498,531.
  • YVONNE HUI (Principal Accounting Officer) has made 0 purchases and 9 sales selling 5,504 shares for an estimated $126,927.
  • LISA EGBUONU-DAVIS sold 1,400 shares for an estimated $32,239

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PHR Hedge Fund Activity

We have seen 102 institutional investors add shares of $PHR stock to their portfolio, and 67 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.


This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.